The data from meta-analysis showed a significant increase in frequency of ERCC1 8092AA genotype in glioma patients than in controls, indicating that ERCC1 8092AA genotype contribute to increases the risk of glioma with combined OR of 1.29 (1.07–1.55). This evidence concerns the gene ERCC1 and central nervous system cancer.